Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Clarke

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Rheumatology Advances in Practice|May 17, 2023
Treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scopeSizheng Steven Zhao, Stephanie R Harrison, Antoni Chan, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
Inhalation by design: dual pharmacology β-2 agonists/M3 antagonists for the treatment of COPDLyn H Jones, Helen Baldock, Mark E Bunnage, et al.
Rheumatology (Oxford, England)|April 8, 2025
Executive Summary: The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDsSizheng Steven Zhao, Stephanie R Harrison, Ben Thompson, et al.
Rheumatology (Oxford, England)|April 8, 2025
The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDsSizheng Steven Zhao, Stephanie R Harrison, Ben Thompson, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Rheumatology Advances in Practice|May 17, 2023
Treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scopeSizheng Steven Zhao, Stephanie R Harrison, Antoni Chan, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
Inhalation by design: dual pharmacology β-2 agonists/M3 antagonists for the treatment of COPDLyn H Jones, Helen Baldock, Mark E Bunnage, et al.
Rheumatology (Oxford, England)|April 8, 2025
Executive Summary: The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDsSizheng Steven Zhao, Stephanie R Harrison, Ben Thompson, et al.
Rheumatology (Oxford, England)|April 8, 2025
The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDsSizheng Steven Zhao, Stephanie R Harrison, Ben Thompson, et al.
Pageof 3